Thursday, July 7, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Biology

Probiotic Lactobacillus acidophilus shows promise for treating inflammatory bowel disease and other

April 20, 2021
in Biology
0
Share on FacebookShare on Twitter

Probiotic strain LA1 has a therapeutic effect that both prevents and treats intestinal inflammatory disorders caused by “leaky gut,” report researchers in The American Journal of Pathology

IMAGE

Credit: Rana Al-Sadi, PhD

Philadelphia, April 20, 2021 – Intestinal epithelial tight junctions (TJs) act as a functional and structural barrier against harmful antigens that promote intestinal inflammation in inflammatory bowel disease (IBD) and other inflammatory conditions of the gut. A defective intestinal TJ barrier, sometimes known as “leaky gut,” plays an important role in exacerbating and prolonging intestinal inflammation. New research reported in The American Journal of Pathology, published by Elsevier, shows that the probiotic Lactobacillus acidophilus (L. acidophilus) strain known as LA1 can generate a rapid and sustained enhancement of this defective intestinal barrier and effectively treat intestinal inflammation by preserving and restoring the intestinal barrier.

The use of probiotics has emerged as a therapy for a number of intestinal disorders, including IBD and necrotizing enterocolitis; however, specific probiotic bacteria with true beneficial effects on intestinal disease need to be identified. In this study researchers used high-throughput screening to assess over 20 probiotic bacteria to determine their ability to increase intestinal barrier function, using both a cell culture model of the intestinal epithelial lining and live mice.

The probiotic bacterial species L. acidophilus, specifically the LA1 strain, produced a rapid and marked increase in intestinal TJ barrier; other strains within L. acidophilus had no effect. The researchers found that this particular strain interacted with intestinal cells in a unique way to activate pathways that tightened the intestinal barrier, treating intestinal inflammation. It attaches to the intestinal epithelial membrane surface by directly interacting with the toll-like receptor-2 complex, which alerts the intestine to trigger an immune response.

The researchers also performed in vivo proof-of-concept studies in live mice to investigate the effect of LA1 and another strain, LA3, in the enhancement of mouse intestinal barrier and the therapeutic efficacy of LA1 in maintaining intestinal barrier and protecting against induced colitis. They found that LA1, but not LA3, caused rapid and marked enhancement of small intestine and colonic epithelial barrier in mice. Treatment studies after the onset of colitis found that LA1 was also effective in the healing of intestinal barrier and colitis.

“Our data indicate that LA1 is able to prevent colonic inflammation formation and promote colitis healing,” said lead investigator Thomas Ma, MD, PhD, Penn State College of Medicine, Hershey Medical Center, Hershey, PA, USA. “The implications of the present findings are that this bacterial strain can be used in a wide variety of intestinal permeability disorders, including IBD, coeliac disease, alcoholic liver disease, non-alcoholic fatty liver disease, and necrotizing enterocolitis, to treat inflammation associated with the leaky gut.”

L. acidophilus is found in various brands of yogurt including Chobani, Dannon, Siggi’s, Stonyfield, and Yoplait.

###

Media Contact
Eileen Leahy
[email protected]

Related Journal Article

http://dx.doi.org/10.1016/j.ajpath.2021.02.003

Tags: BacteriologyCell BiologyGastroenterologyMedicine/HealthNutrition/Nutrients
Share25Tweet16Share4ShareSendShare
  • PAN protein domain

    Scientists discover cancer trigger that could spur targeted drug therapies

    80 shares
    Share 32 Tweet 20
  • COVID-19 fattens up our body’s cells to fuel its viral takeover

    103 shares
    Share 41 Tweet 26
  • Killing resistant prostate cancer with iron

    67 shares
    Share 27 Tweet 17
  • Messenger RNA technology shows promise for developing infectious disease therapeutics

    66 shares
    Share 26 Tweet 17
  • ‘Supergene’ wreaks havoc in a genome

    66 shares
    Share 26 Tweet 17
  • How bilingual brains work: Cross-language interplay and an integrated lexicon

    65 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

COVID-19 fattens up our body’s cells to fuel its viral takeover

Scientists discover cancer trigger that could spur targeted drug therapies

Immune molecules from a llama could provide protection against a vast array of SARS-like viruses including COVID-19, researchers say

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 190 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....